Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
468.08
-4.63 (-0.98%)
Mar 18, 2026, 11:50 AM EDT - Market open

Thermo Fisher Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21 Apr '21
Cash & Equivalents
9,8521,9824,5764,1344,0094,6457,0735,4998,0776,1513,1333,4828,5242,9191,8882,7524,47712,0277,0235,583
Short-Term Investments
2531,5641,8141,8131,5612,0001,7501,7513-----------
Cash & Short-Term Investments
10,1053,5466,3905,9475,5706,6458,8237,2508,0806,1513,1333,4828,5242,9191,8882,7524,47712,0277,0235,583
Cash Growth
81.42%-46.64%-27.58%-17.97%-31.06%8.03%181.61%108.21%-5.21%110.72%65.94%26.53%90.40%-75.73%-73.12%-50.71%-56.64%59.51%20.71%87.29%
Accounts Receivable
8,9008,9118,5948,4558,1918,2557,9437,9318,2218,3708,0197,9228,1157,6717,7457,8897,9775,5575,4765,554
Inventory
5,4255,7455,5595,2244,9785,4305,1985,1335,0885,4045,6555,6645,6345,7225,6685,4835,0514,9064,6254,342
Other Current Assets
4,2784,0924,0403,7533,3993,4523,5123,3263,2003,1673,1883,1412,9562,9872,7992,6522,6082,2342,1362,206
Total Current Assets
28,70722,29524,58423,37822,13723,78325,47623,64024,58923,09219,99520,20925,22919,29918,10018,77620,11324,72419,26017,685
Net Property, Plant & Equipment
10,56510,1779,6359,3319,3069,4129,2829,3249,4489,1679,2929,3549,2808,6288,5298,4488,3337,0496,5606,133
Other Intangible Assets
15,83816,24215,14815,32315,53316,26215,51916,04816,67017,09117,43717,97217,44217,81318,57819,37820,11311,92712,39012,831
Goodwill
49,36249,28747,24946,49345,85346,72643,84343,84344,02043,58343,27343,14041,19640,48841,06641,72141,92426,90926,90426,823
Other Long-Term Assets
5,8715,0194,6154,5164,4924,1804,3774,2413,9994,1244,1083,9834,0074,3084,3064,4244,6402,9912,5842,459
Total Assets
110,343103,020101,23099,04197,321100,36498,49697,09598,72697,05794,10594,65897,15490,53690,57992,74795,12373,60067,69865,931
Accounts Payable
3,6223,1202,9803,0493,0792,6062,5472,5552,8722,5082,4232,7983,3812,4712,5862,6672,8672,3012,0982,146
Accrued Expenses
5,3245,0934,7184,4415,1875,2164,5144,2994,8424,3084,2854,3025,4495,0704,6794,6665,3773,9913,3533,449
Short-Term Debt
3,5333,8232,2142,8192,2144,1165,1214,4513,6094,7954,8146,1225,5791,0101,0101,8662,5371944
Unearned Revenue
2,7102,8522,8052,8662,8522,6632,5912,6322,6892,5472,5902,6622,6012,5672,7222,8712,6551,4421,4701,396
Total Current Liabilities
15,18914,88812,71813,17413,33214,60114,77213,93714,01214,15814,11215,88417,01011,11810,99712,07013,4367,7536,9256,995
Long-Term Debt
35,85231,85733,01531,37029,06131,19730,28431,15731,30830,48929,19429,13528,90928,15029,25031,38932,33321,68818,77318,641
Other Long-Term Liabilities
5,7665,1204,8941,0415,2575,4665,9076,3786,5646,9466,8847,2067,0877,5417,8618,1578,3775,4495,1465,237
Total Long-Term Liabilities
41,61836,97737,90932,41134,31836,66336,19137,53537,87237,43536,07836,34135,99635,69137,11139,54640,71027,13723,91923,878
Total Liabilities
56,80751,86550,62745,58547,65051,26450,96351,47251,88451,59350,19052,22553,00646,80948,10851,61654,14634,89030,84430,873
Preferred Stock
-----------------439--
Common Stock
445445444444444444443443442442441441441440440440439-438438
Treasury Stock
-22,309-22,310-21,269-21,269-19,226-18,227-18,187-18,186-15,133-15,121-15,084-15,083-12,017-11,011-10,964-10,961-8,922-8,911-8,856-8,852
Additional Paid-in Capital
18,56318,33018,23218,11117,96217,83117,64917,48217,28617,16517,03016,88916,74316,59616,46716,29216,17415,96015,82615,684
Accumulated Other Comprehensive Income
-2,448-2,801-2,797-2,343-2,697-2,477-2,413-2,764-3,224-3,027-2,924-3,054-3,099-2,928-2,724-2,343-2,329-2,654-2,630-2,562
Retained Earnings
59,15657,35455,90154,44753,10251,42149,94048,54247,36445,86944,28943,06441,91040,45239,07437,52835,43133,87632,07630,350
Total Common Shareholders' Equity
53,40751,01850,51249,39049,58448,99247,43245,51646,73545,32843,75242,25743,97843,54942,29340,95640,79338,71036,85435,058
Minority Interest
129136919587107103107107136163176170178178175184---
Shareholders' Equity
53,53751,15350,60249,48549,67149,09947,53445,62346,84245,46443,91542,43344,14843,72742,47141,13140,97738,71036,85435,058
Total Liabilities & Equity
110,343103,020101,23099,04197,321100,36498,49697,09598,72697,05794,10594,65897,15490,53690,57992,74795,12373,60067,69865,931
Total Debt
39,38535,68035,22934,18931,27535,31335,40535,60834,91735,28434,00835,25734,48829,16030,26033,25534,87021,70718,77718,645
Net Cash (Debt)
-29,280-32,134-28,839-28,242-25,705-28,668-26,582-28,358-26,837-29,133-30,875-31,775-25,964-26,241-28,372-30,503-30,393-9,680-11,754-13,062
Net Cash Per Share
-77.67-85.01-76.29-74.52-67.11-74.66-69.41-73.85-69.17-75.08-79.58-81.89-66.07-66.43-72.01-77.22-76.36-24.38-29.68-32.90
Book Value
53,40751,01850,51249,39049,58448,99247,43245,51646,73545,32843,75242,25743,97843,54942,29340,95640,79338,71036,85435,058
Book Value Per Share
141.66134.97133.63130.32129.46127.58123.84118.53120.45116.82112.76108.91111.90110.25107.34103.69102.4997.5193.0788.31
Tangible Book Value
-11,793-14,511-11,885-12,426-11,802-13,996-11,930-14,375-13,955-15,346-16,958-18,855-14,660-14,752-17,351-20,143-21,244-126-2,440-4,596
Tangible Book Value Per Share
-31.28-38.39-31.44-32.79-30.81-36.45-31.15-37.43-35.97-39.55-43.71-48.60-37.30-37.35-44.04-50.99-53.38-0.32-6.16-11.58
Updated Jan 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q